1. International Diabetes Federation . IDF diabetes atlas – across the globe. IDF diabetes Atlas. 8th ed. Brussels: International Diabetes Federation, 2017.
Google Scholar2. Yusuf, PS, Hawken, S, Ôunpuu, S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937–952.
Google Scholar | Crossref | Medline3. Gansevoort, RT, Correa-Rotter, R, Hemmelgarn, BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013; 382: 339–352.
Google Scholar | Crossref | Medline4. Carone, FA, Peterson, DR. Hydrolysis and transport of small peptides by the proximal tubule. Am J Physiol 1980; 238: F151–F158.
Google Scholar | Medline5. Mak, RHK, DeFronzo, RA. Glucose and insulin metabolism in uremia. Nephron 1992; 61: 377–382.
Google Scholar | Crossref | Medline6. Rabkin, R, Simon, NM, Steiner, S, et al. Effect of renal disease on renal uptake and excretion of insulin in man. N Engl J Med 1970; 282: 182–187.
Google Scholar | Crossref | Medline7. Adrogue, HJ . Glucose homeostasis and the kidney. Kidney Int 1992; 42: 1266–1282.
Google Scholar | Crossref | Medline8. Fliser, D, Pacini, G, Engelleiter, R, et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998; 53: 1343–1347.
Google Scholar | Crossref | Medline9. Castellino, P, Solini, A, Luzi, L, et al. Glucose and amino acid metabolism in chronic renal failure: effect of insulin and amino acids. Am J Physiol 1992; 262: F168–F176.
Google Scholar | Medline10. Alvestrand, A, Wahren, J, Smith, D, et al. Insulin-mediated potassium uptake is normal in uremic and healthy subjects. Am J Physiol 1984; 246: E174–E180.
Google Scholar | Medline11. McCaleb, ML, Izzo, MS, Lockwood, DH. Characterization and partial purification of a factor from uremic human serum that induces insulin resistance. J Clin Invest 1985; 75: 391–396.
Google Scholar | Crossref | Medline12. Mak, RHK . Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 1992; 41: 1049–1054.
Google Scholar | Crossref | Medline13. Kautzky-Willer, A, Pacini, G, Barnas, U, et al. Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int 1995; 47: 200–206.
Google Scholar | Crossref | Medline14. Lin, SH, Lin, YF, Lu, KC, et al. Effects of intravenous calcitriol on lipid profiles and glucose tolerance in uraemic patients with secondary hyperparathyroidism. Clin Sci 1994; 87: 533–538.
Google Scholar | Crossref15. Perna, AF, Fadda, GZ, Zhou, XJ, et al. Mechanisms of impaired insulin secretion after chronic excess of parathyroid hormone. Am J Physiol 1990; 259: F210–F216.
Google Scholar | Medline16. Hajjar, SM, Fadda, GZ, Thanakitcharu, P, et al. Reduced activity of Na+-K+ ATPase of pancreatic islets in chronic renal failure: role of secondary hyperparathyroidism. J Am Soc Nephrol 1992; 2: 1355–1359.
Google Scholar | Crossref | Medline17. Oh, HY, Fadda, GZ, Smogorzewski, M, et al. Abnormal leucine-induced insulin secretion in chronic renal failure. Am J Physiol 1994; 267: F853–F860.
Google Scholar18. Daniels, ID, Markell, MS. Blood glucose control in diabetics: II. Semin Dial 1993; 6: 394–397.
Google Scholar | Crossref19. Jørgensen, MB, Idorn, T, Knop, FK, et al. Clearance of glucoregulatory peptide hormones during haemodialysis and haemodiafiltration in non-diabetic end-stage renal disease patients. Nephrol Dial Transplant 2015; 30: 513–520.
Google Scholar | Crossref | Medline20. Chu, YW, Lin, HM, Wang, JJ, et al. Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis: a national cohort study. PLoS ONE 2017; 12: e0174601.
Google Scholar | Crossref21. Scott, MG, Hoffmann, JW, Meltzer, VN, et al. Effects of azotemia on results of the boronate-agarose affinity and ion-exchange methods for glycated hemoglobin. Clin Chem 1984; 30: 896–898.
Google Scholar | Crossref | Medline22. Paisey, R, Banks, R, Holton, R, et al. Glycosylated haemoglobin in uraemia. Diabet Med 1986; 3: 445–448.
Google Scholar | Crossref | Medline23. Joske, RA, McAlister, JM, Prankerd, TA. Isotope investigations of red cell production and destruction in chronic renal disease. Clin Sci 1956; 15: 511–522.
Google Scholar | Medline24. Ly, J, Marticorena, R, Donnelly, S. Red blood cell survival in chronic renal failure. Am J Kidney Dis 2004; 44: 715–719.
Google Scholar | Crossref | Medline25. Inaba, M, Okuno, S, Kumeda, Y, et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 2007; 18: 896–903.
Google Scholar | Crossref | Medline26. Sabater, J, Quereda, C, Herrera, I, et al. Nonenzymatic glycosylation of hemoglobin and total plasmatic proteins in end-stage renal disease. Am J Nephrol 1991; 11: 37–43.
Google Scholar | Crossref | Medline27. Flückiger, R, Harmon, W, Meier, W, et al. Hemoglobin carbamylation in uremia. N Engl J Med 1981; 304: 823–827.
Google Scholar | Crossref | Medline28. Coban, E, Ozdogan, M, Timuragaoglu, A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol 2004; 112: 126–128.
Google Scholar | Crossref | Medline29. De Marchi, S, Cecchin, E, Camurri, C, et al. Origin of glycosylated hemoglobin A1 in chronic renal failure. Int J Artif Organs 1983; 6: 77–82.
Google Scholar | SAGE Journals30. Joy, MS, Cefalu, WT, Hogan, SL, et al. Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis 2002; 39: 297–307.
Google Scholar | Crossref | Medline31. Freedman, BI, Shihabi, ZK, Andries, L, et al. Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease. Am J Nephrol 2010; 31: 375–379.
Google Scholar | Crossref | Medline32. Freedman, BI, Andries, L, Shihabi, ZK, et al. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. Clin J Am Soc Nephrol 2011; 6: 1635–1643.
Google Scholar | Crossref | Medline33. Jung, M, Warren, B, Grams, M, et al. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: results from the Atherosclerosis Risk in Communities Study. J Diabetes 2018; 10: 276–285.
Google Scholar | Crossref | Medline34. Battelino, T, Danne, T, Bergenstal, RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 2019; 42: 1593–1603.
Google Scholar | Crossref | Medline35. Bergenstal, RM, Beck, RW, Close, KL, et al. Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Diabetes Care 2018; 41: 2275–2280.
Google Scholar | Crossref | Medline36. Frankel, AH, Kazempour-Ardebili, S. Management of adults with diabetes on the haemodialysis unit. Jt Br Diabetes Soc Inpatient Care. http://www.diabetologists-abcd.org.uk/JBDS/JBDS_RenalGuide_2016.pdf (2016)
Google Scholar37. Hill, CJ, Maxwell, AP, Cardwell, CR, et al. Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis. Am J Kidney Dis 2014; 63: 84–94.
Google Scholar | Crossref | Medline38. Papademetriou, V, Lovato, L, Doumas, M, et al. Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes. Kidney Int 2015; 87: 649–659.
Google Scholar | Crossref | Medline39. Ramirez, SPB, McCullough, KP, Thumma, JR, et al. Hemoglobin A1c levels and mortality in the diabetic hemodialysis population: findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Diabetes Care 2012; 35: 2527–2532.
Google Scholar | Crossref | Medline40. Mak, RHK . Impact of end-stage renal disease and dialysis on glycemic control. Semin Dial 2000; 13: 4–8.
Google Scholar | Crossref | Medline41. Montoliu, J, Revert, L. Lethal hyperkalemia associated with severe hyperglycemia in diabetic patients with renal failure. Am J Kidney Dis 1985; 5: 47–48.
Google Scholar | Crossref | Medline42. Sharif, A, Hecking, M, de Vries, AP, et al. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant 2014; 14: 1992–2000.
Google Scholar | Crossref | Medline43. Davidson, J, Wilkinson, A, Dantal, J, et al. New-onset diabetes after transplantation: 2003 International Consensus Guidelines. Proceedings of an International Expert Panel Meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003; 75: SS3–SS24.
Google Scholar | Crossref44. Valderhaug, TG, Jenssen, T, Hartmann, A, et al. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation 2009; 88: 429–434.
Google Scholar | Crossref | Medline45. David-Neto, E, Lemos, FC, Fadel, LM, et al. The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patients. Transplantation 2007; 84: 50–55.
Google Scholar | Crossref | Medline46. Porrini, E, Moreno, JM, Osuna, A, et al. Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter study. Transplantation 2008; 85: 1133–1138.
Google Scholar | Crossref | Medline47. Mourad, G, Glyda, M, Albano, L, et al. Incidence of posttransplantation diabetes mellitus in de novo kidney transplant recipients receiving prolonged-release tacrolimus-based immunosuppression with 2 different corticosteroid minimization strategies: ADVANCE, a randomized controlled trial. Transplantation 2017; 101: 1924–1934.
Google Scholar | Crossref | Medline48. Lentine, KL, Brennan, DC, Schnitzler, MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005; 16: 496–506.
Google Scholar | Crossref | Medline49. Ducloux, D, Kazory, A, Chalopin, JM. Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: a prospective study. Transplantation 2005; 79: 438–443.
Google Scholar | Crossref | Medline50. Miles, AMV, Sumrani, N, Horowitz, R, et al. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplantation 1998; 65: 380–384.
Google Scholar | Crossref | Medline51. Cole, EH, Johnston, O, Rose, CL, et al. Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival. Clin J Am Soc Nephrol 2008; 3: 814–821.
Google Scholar | Crossref | Medline52. Ojo, AO . Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006; 82: 603–611.
Google Scholar | Crossref | Medline53. Caillard, S, Eprinchard, L, Perrin, P, et al. Incidence and risk factors of glucose metabolism disorders in kidney transplant recipients: role of systematic screening by oral glucose tolerance test. Transplantation 2011;